A large trial presented at the ESC Congress 2026 reveals that a one-year exercise intervention cuts atrial fibrillation burden by 45% and lowers hospitalizations. Meanwhile, separate Norwegian research published in the Journal of the American Heart Association shows that regular physical activity reduces stroke risk and extends life expectancy for patients with the heart rhythm disorder.
Atrial fibrillation, a common heart rhythm disorder marked by a rapid and irregular heartbeat, places patients at a heightened risk of stroke and cardiovascular complications. While lifestyle modifications remain a cornerstone of management, structured exercise programs are frequently underutilized in clinical practice. Data from the European Heart Rhythm Association indicates that roughly only 1 in 10 eligible patients receive referrals for exercise-based rehabilitation.
The NEXAF Trial: How a Hybrid Exercise Model Cuts Atrial Fibrillation Burden
To address this clinical gap, researchers designed the NEXAF trial to evaluate a structured, one-year physical activity intervention for symptomatic patients. Conducted across three centers in Norway, the trial enrolled 295 participants with non-permanent atrial fibrillation and baseline activity levels below standard public health recommendations. Investigators randomized the participants in a 1-year follow-up comparing supervised and remote-supported exercise against standard medical care.
The intervention combined short-term supervision with long-term home-based support. Patients completed eight supervised high-intensity sessions during their initial four to six weeks. Afterward, they relied on remote monitoring via a smartwatch, a dedicated application, and a web-based platform. By contrast, the control group received routine medical treatment without any structured physical activity program. Every participant had an insertable cardiac monitor implanted to track heart rhythms continuously.
“In this large, randomized trial, a one-year exercise intervention induced a meaningful reduction in total AF burden, improved fitness and led to fewer AF-related hospital admissions compared to usual care.”
Doctor Bjarne Nes, Principal Investigator of the NEXAF trial, Norwegian University of Science and Technology
The results showed a significant divergence between the two groups. Patients assigned to the exercise program achieved a 45% relative reduction in their atrial fibrillation burden—measured as the percentage of monitored time spent in the rhythm disorder—dropping to 3.9% compared to 7.1% in the usual-care arm. Beyond the primary rhythm endpoint, the intervention group demonstrated tangible improvements in cardiorespiratory fitness and resting heart rate.
Hospitalizations Drop While Quality of Life Scores Remain Steady
The physiological gains translated directly into reduced utilization of acute medical care. Researchers documented a 37% drop in total hospitalizations alongside a 46% decrease in hospital admissions specifically related to atrial fibrillation. Despite these clear clinical gains, the trial recorded no statistically significant difference in disease-specific quality of life scores between the active intervention group and the control group at the one-year mark.
Doctor Nes emphasized that the hybrid delivery model required modest personnel resources, proving that digital support and home monitoring can make structured cardiac rehabilitation clinically feasible on a broader scale. The findings add rigorous trial data to support the first dedicated ESC Guidelines on cardiac rehabilitation published recently in the European Heart Journal.
Long-Term Norwegian Population Data Links Exercise to Lower Stroke Risk
Complementing the trial findings, observational data published by the Journal of the American Heart Association demonstrates that physical activity offers substantial cerebrovascular protection for individuals managing the condition. That expansive study tracked more than 87,340 adults in Norway—including 6,539 patients living with atrial fibrillation—over a median follow-up period of 13.5 years.
Participants self-reported their exercise habits, allowing researchers to categorize activity into inactive, low, moderate, and high tiers. The moderate bracket met standard public health guidelines through daily moderate-intensity movement, while the high bracket performed vigorous exercise for at least 30 minutes nearly every day. The data revealed that participants with moderate or high physical activity levels lowered their stroke risk by nearly 20% compared to inactive peers. Crucially, even low-intensity activity provided measurable protection, reducing stroke incidence by 9%.
| Activity Level | Description | Stroke Risk Reduction | All-Cause Mortality Reduction |
|---|---|---|---|
| Low | Moderate intensity for under 15 minutes daily | 9% | 11% |
| Moderate | Meets standard guidelines (30 minutes daily) | Nearly 20% | 18% |
| High | Vigorous exercise for 30 minutes daily | Nearly 20% | 22% |
Furthermore, staying active mitigated overall mortality risks across the entire cohort. Low, moderate, and high activity levels decreased the risk of death from any cause by 11%, 18%, and 22%, respectively. For patients diagnosed with atrial fibrillation, maintaining an active lifestyle was associated with living an average of six to 14 months longer than inactive individuals, reinforcing the clinical consensus that physical movement remains a powerful tool in long-term cardiovascular care.
По теме
